| 注册
首页|期刊导航|中国实用神经疾病杂志|脊髓小脑性共济失调2两家系致病基因及临床特点

脊髓小脑性共济失调2两家系致病基因及临床特点

周海涛 牛宇杰 刘德全 潘社红 任向阳 李玉林 王云龙

中国实用神经疾病杂志2024,Vol.27Issue(1):15-19,5.
中国实用神经疾病杂志2024,Vol.27Issue(1):15-19,5.DOI:10.12083/SYSJ.221812

脊髓小脑性共济失调2两家系致病基因及临床特点

Pathogenic genes and clinical characteristics of spinocerebellar ataxia 2 in two families

周海涛 1牛宇杰 2刘德全 3潘社红 4任向阳 3李玉林 5王云龙5

作者信息

  • 1. 郑州大学附属洛阳中心医院,河南 洛阳 471009||郑州大学附属洛阳中心医院中心实验室,河南 洛阳 471009||河南省肿瘤细胞免疫与再生医学国际联合实验室,河南 洛阳 471009
  • 2. 郑州大学附属洛阳中心医院中心实验室,河南 洛阳 471009||河南省肿瘤细胞免疫与再生医学国际联合实验室,河南 洛阳 471009
  • 3. 郑州大学附属洛阳中心医院,河南 洛阳 471009
  • 4. 洛阳市第九人民医院,河南 洛阳 471009
  • 5. 河南省生物工程技术研究中心,河南 郑州 450001
  • 折叠

摘要

Abstract

Objective To analyze the pathogenic genes and clinical characteristics of spinocerebellar ataxias(SCAs)in two pedigrees in Luoyang.Methods Clinical data of the proband and pedigree members were collected.After peripheral venous blood DNA was extracted,polymerase chain reaction(PCR)and agarose gel electrophoresis were used to screen SCA1,2,3,6,7,12,17 and DRPLA subtypes in the two probands.Sanger sequencing was performed on the target subtypes after the preliminary determination of the subtypes.After confirmation,other members of the pedigree were verified.Results The probands of family 1 and family 2 were all subtype SCA2,and the repeat times of CAG in pathogenic allele were 44 and 38,respectively.The subsequent family verification showed that there were 3 pathogenic gene carriers in pedigree 1 and 1 pathogenic gene carrier in pedigree 2.All the probands had walking instability as the main symptom,and some of them had slurred speech and memory deterioration.Conclusion Two SCA2 pedigrees in Luoyang were diagnosed by combined PCR and Sanger sequencing.Familial walking instability is the main clinical feature.

关键词

脊髓小脑性共济失调/聚合酶链反应/Sanger测序/SCA2亚型/临床特点/行走不稳

Key words

Spinocerebellar ataxia/Polymerase chain reaction/Sanger sequencing/Subtype SCA2/Clinical characteristics/Walking instability

分类

医药卫生

引用本文复制引用

周海涛,牛宇杰,刘德全,潘社红,任向阳,李玉林,王云龙..脊髓小脑性共济失调2两家系致病基因及临床特点[J].中国实用神经疾病杂志,2024,27(1):15-19,5.

基金项目

河南省重点研发与推广专项(编号:222102310113) (编号:222102310113)

洛阳市科技发展计划项目(编号:2101042A) (编号:2101042A)

中国实用神经疾病杂志

OACSTPCD

1673-5110

访问量0
|
下载量0
段落导航相关论文